Skip to main content
Article
Partial agonist effect influences the CTL response to a heterologous dengue virus serotype
Morningside Graduate School of Biomedical Sciences Student Publications
  • Jaroslav Zivny, University of Massachusetts Medical School
  • Matthew DeFronzo, University of Massachusetts Medical School
  • William Jarry, University of Massachusetts Medical School
  • Julie Marie Jameson, University of Massachusetts Medical School
  • John Cruz, University of Massachusetts Medical School
  • Francis A. Ennis, University of Massachusetts Medical School
  • Alan L. Rothman, University of Massachusetts Medical School
UMMS Affiliation
Graduate School of Biomedical Sciences; Center for Infectious Disease and Vaccine Research; Department of Medicine, Division of Gastroenterology; Department of Medicine, Division of Infectious Diseases and Immunology
Publication Date
1999-8-24
Document Type
Article
Abstract

Activation of dengue serotype-cross-reactive memory CTL during secondary dengue virus (DV) infection is thought to be important in the pathogenesis of dengue hemorrhagic fever. To model this effect, we studied the CTL responses to DV types 2 (D2V) and 3 (D3V) in PBMC from an individual previously infected with D3V. DV-specific CD8+ CTL from this donor recognized two HLA-B62-restricted epitopes on the NS3 protein, aa 71-79 (SVKKDLISY) and 235-243 (AMKGLPIRY). Both D3V-specific and D2V/D3V-cross-reactive CTL clones were detected for each epitope; all D2V-reactive CTL clones could lyse D2V-infected autologous cells. CTL responses to both epitopes were detected in bulk cultures stimulated with D3V, but PBMC stimulated with D2V recognized only the 235-243 epitope. IFN-gamma enzyme-linked immunospot assay showed that the D2V (71-79) peptide (DVKKDLISY) did not efficiently activate T cells. Analysis of a CTL clone suggests that the D2V (71-79) peptide acts as a partial agonist, able to sensitize target cells for lysis and inducing only minimal proliferation at high concentrations. These results suggest that variant peptide sequences present in the heterologous DV serotype can influence the CTL response in vivo during secondary DV infection.

Source

J Immunol. 1999 Sep 1;163(5):2754-60.

Related Resources

Link to Article in PubMed

PubMed ID
10453018
Citation Information
Jaroslav Zivny, Matthew DeFronzo, William Jarry, Julie Marie Jameson, et al.. "Partial agonist effect influences the CTL response to a heterologous dengue virus serotype" Vol. 163 Iss. 5 (1999) ISSN: 0022-1767 (Print)
Available at: http://works.bepress.com/alan_rothman/23/